Athersys Inc.

In News

Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M - Yahoo Finance

Yahoo Finance - Nov 11, 2025

Athersys files for bankruptcy, sells assets to Healios in wake of stroke cell therapy’s struggles - Fierce Biotech

Fierce Biotech - Jan 09, 2024

Healios posts more upbeat data on Multistem cell therapy for ARDS - BioWorld MedTech

BioWorld MedTech - Mar 18, 2025

Healios Acquires Bankrupt Athersys, Expands Cell Therapy R&D Programs - Citeline News & Insights

Citeline News & Insights - Apr 05, 2024

Bankrupt Athersys Inc. sells its assets for $2.25 million - Crain's Cleveland Business

Crain's Cleveland Business - Apr 08, 2024

Athersys shares suspended by Nasdaq, now trading over the counter - Cleveland.com

Cleveland.com - Oct 24, 2023

Bankruptcy of once-promising Athersys winding down with assets sale - The Business Journals

The Business Journals - Apr 08, 2024

Athersys signs licensing agreement with Ardent Animal Health - DVM360

DVM360 - Oct 09, 2023

Stem cell treatment for stroke shows promising results, study finds - OHSU News

OHSU News - Mar 17, 2017

Athersys, Inc. Announces Closing of $5.5 Million Confidentially Marketed Public Offering - The Globe and Mail

The Globe and Mail - Nov 10, 2022

Athersys' struggles mount with employee terminations, Nasdaq delisting upcoming - Crain's Cleveland Business

Crain's Cleveland Business - Jan 03, 2024

Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal - Yahoo Finance

Yahoo Finance - May 23, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment